Characterization of Preparations of GAD65, Proinsulin, and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T-Cells in Type 1 Diabetes
Open Access
- 1 August 2001
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (8) , 1749-1754
- https://doi.org/10.2337/diabetes.50.8.1749
Abstract
The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase–like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.Keywords
This publication has 18 references indexed in Scilit:
- Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4Journal of Clinical Investigation, 1999
- Autoreactive T cell Responses in Insulin-dependent (Type 1) Diabetes Mellitus. Report of the First International Workshop for Standardization of T cell assaysJournal of Autoimmunity, 1999
- GAD65-Reactive T cells in a Non-diabetic Stiff-man Syndrome PatientJournal of Autoimmunity, 1999
- Cloned T Cells from a Recent Onset IDDM Patient Reactive with Insulin B-chainJournal of Autoimmunity, 1998
- High Affinity Presentation of an Autoantigenic Peptide in Type I Diabetes by an HLA Class II Protein Encoded in a Haplotype Protecting From DiseaseJournal of Autoimmunity, 1997
- Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.Journal of Clinical Investigation, 1997
- Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD miceDiabetes, 1994
- Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantationThe Lancet, 1993
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988